Meeting
2023 ASCO Annual Meeting
Neoplastic and blood-based biomarkers of response in patients with advanced endometrial cancer: Results from NRG GY012.
Authors
Helen Mackay
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
Helen Mackay , Andrew B. Nixon , Danielle Enserro , David Bender , BJ Rimel , Matthew A. Powell , Debra L. Richardson , Laura L. Holman , Nitya Alluri , Cara Amanda Mathews , Ruchi Garg , Sarah Gill , Daniela Matei , Charles A. Leath III, Floor Jenniskens Backes , Aimee Fleury , Elizabeth M. Swisher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT03660826
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5525)
DOI
10.1200/JCO.2023.41.16_suppl.5525
Abstract #
5525
Poster Bd #
220
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.
First Author: Joseph W. Kim
Poster
2023 ASCO Annual Meeting
Comprehensive profiling of mutational signatures and machine learning and subtypes of homologous recombination deficiency.
First Author: Joonoh Lim
Poster
2023 ASCO Annual Meeting
HRD signature and HRD genomic landscape of tumors from 896 patients with early-stage breast cancer (BC).
First Author: June Evelyn Jeon
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou